BPG is committed to discovery and dissemination of knowledge
Opinion Review
Copyright: ©Author(s) 2026.
World J Psychiatry. Aug 19, 2026; 16(8): 116224
Published online Aug 19, 2026. doi: 10.5498/wjp.116224
Figure 1
Figure 1 Sites of action (efficacy) of celecoxib and duloxetine. Celecoxib inhibits the cyclooxygenase-2 enzyme, reducing the production of prostaglandin E2 at the site of inflammation. Duloxetine increases serotonin and norepinephrine in the synaptic cleft, reinforcing the descending inhibitory pathway. COX-2: Cyclooxygenase-2.


Write to the Help Desk